Fourth, some medications that affect bone health (e.g., bisphosphonates, aromatase inhibitors, gonadotropin-releasing hormone analogs or luteinizing hormone releasing agonists, antiandrogens, and Paget’s disease treatment) were not controlled for confounders. The gene discussed is CYP19A1; the disease is Paget disease.